Schonfeld Strategic Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 42,614 shares of AMPH stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,614
Previous 9,607
343.57%
Holding current value
$1.19 Million
Previous $466,000
239.48%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$166 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$75.8 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$51.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$44.5 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$38.4 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.37B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...